The two-electron reducing agent is NADH and the enzyme requires a FAD cofactor close to the active-site Hg-binding cysteines, which operate through a mechanism possibly similar to that of the enzyme glutathione reductase ( vide infra ) [92,93,94]
Long-term PPI users should discuss B12 monitoring with their GP if symptoms of deficiency develop
But new research suggests theres another target for mycotoxins: the gut
It has been the subject of over 100 peer-reviewed preclinical studies examining its potential roles in tissue repair, gut healing, tendon and ligament recovery, and neuroprotection
Gut and inflammation: Individuals with persistent digestive discomfort where gut barrier support is clinically relevant, people with suspected gut-inflammation overlap contributing to fatigue or poor systemic recovery, and those with a history of NSAID-related gut irritation